Introduction {#sec1-1}
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Haloperidol, a butyrophenone neuroleptic drug, is an antipsychotic used in the treatment of adult schizophrenia and mania.\[[@ref1]\] It has been used for the management of various psychotic disorders in adults and for hyperactivity and behavioral disorders in children.\[[@ref2]\] Neuroleptic drugs block D-1 and D-2 receptors and also H1 and H2, alpha 1 and alpha 2, muscarinic and serotoninergic receptors.\[[@ref2]\] Extrapyramidal reactions occur frequently with haloperidol, and in most patients these reactions consist of parkinsonian symptoms (e.g., marked drowsiness and lethargy, drooling or hypersalivation, fixed stare). It is an uncommon drug for overdose and serious complications may occur following ingestion of haloperidol. There are few case reports of haloperidol poisoning in children mostly in the era before newer selective neuroleptics arrived in the market. We report two siblings who presented as unknown poisoning and were later found to have accidentally consumed haloperidol. Since haloperidol is prescribed to ambulatory patients, unsupervised usage by children can be hazardous and even fatal. This report is intended to alert physicians to haloperidol intoxications including its clinical presentation and treatment.

Case Reports {#sec1-2}
============

 {#sec2-1}

### Case 1 {#sec3-1}

A 6 year old female child was brought with complaints of altered sensorium, persistent vomiting since the last 6 h. The patient responded to deep painful stimuli, and was intermittently agitated, febrile with a pulse of 104/min, respiratory rate 18/min, BP 80/40 mm Hg with excessive sweating. On central nervous system (CNS) examination, the pupils were normal, tone was dystonic with intermittent opisthotonus posturing, exaggerated reflexes and ill-sustained clonus was present. Rest of the systemic examination was normal. The working diagnosis and management was of an unknown poisoning, and on deep probing, the history of alleged ingestion of haloperidol was obtained. The child and her brother had consumed an indeterminate amount of 5 mg haloperidol tablets while playing in the backyard about 7 h prior to admission. These tablets were apparently thrown in the open by a neighbor who was under treatment for schizophrenia. The child was given gastric lavage, started on intravenous fluids, bladder catheterization was done. Blood investigations and electrocardiogram (ECG) were normal. Promethazine hydrochloride 0.1 mg/kg and trihexyphenidyl 2 mg/dose thrice-daily was initiated and later increased to 3 mg/dose in view of persistent dystonia. Patient responded dramatically and regained consciousness after 12 h with complete resolution of dystonia within 72 h.

### Case 2 {#sec3-2}

The younger sibling, a 4 year-old male child was also brought with complaints of excessive sleepiness on the later part of the same day. On examination, he was drowsy but arousable obeying verbal commands but not vocalizing. Though his vitals were stable, he had anticholinergic symptoms such as diaphoresis, hyperthermia and urinary retention. On detailed CNS exam, generalized dystonia with intention tremors, perioral tremors, tongue fasciculations, nystagmus and hypereflexia was present. On further enquiry, it was revealed that he too while playing along with his sister, had consumed an unknown number of the same tablets. He was admitted, and after a stomach wash, started on trihexyphenidyl and symptomatic treatment. After 24 h, his involuntary movements persisted so he was started on promethazine IV 0.1 mg/kg/dose single-dose after which, his symptoms subsided over a period of 72 h after admission and he gradually improved and regained consciousness. On follow-up after 1 week, both siblings were asymptomatic and doing well. Psychiatric evaluation and counseling of the children and parents was done.

Discussion {#sec1-3}
==========

Haloperidol is one of the butyrophenone neuroleptics and has antipsychotic, antianxiety effects. The main features of severe over dosage are extrapyramidal reactions, hypotension, respiratory difficulty and impairment of consciousness. Extrapyramidal reactions occur frequently. Other adverse neuromuscular reactions have been reported less frequently, but are often more severe and include feelings of motor restlessness (i.e., akathisia), tardive dystonia, and dystonic reactions such as hyperreflexia, opisthotonus, oculogyric crisis, torticollis, and trismus. Tremor or muscle twitching, muscle spasm, rigidity and convulsions may also be seen.\[[@ref3]\] Adverse anticholinergic effects of haloperidol include dry mouth (xerostomia), blurred vision, constipation, urinary retention, and diaphoresis. Cardiac effects include hypotension, tachycardia. Sometimes there can be cardiac arrhythmias including ventricular fibrillation, conduction defects and cardiac arrest. There are reports of delayed onset of hypertension, hence inpatient observation of children with accidental haloperidol poisoning is recommended.\[[@ref4]\] Literature shows that haloperidolinduced dystonia occurs more often in children. The neuroleptic malignant syndrome associated with haloperidol is believed to be an idiosyncratic reaction.\[[@ref5]\]

The treatment of acute dystonic reaction, akathisia and parkinsonism observed during the administration of haloperidol includes parenteral administration of antiparkinsonism agents.\[[@ref1][@ref4]\] Drugs that have been used for treatment include biperiden and promethazine, both of which can lead to an immediate improvement. Our patients had parkinsonian symptoms to a varying degree along with anticholinergic symptoms and responded dramatically to antiparkinsonian drugs. The value of a good personal history cannot be understated along with a vigilance to inquire the social and family history.
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